| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenues | $1.07B+11.9% | $957.8M+31.8% | $726.4M+40.4% | $517.2M+6.8% | $484.1M |
| Cost of product sales | $89.0M+8.7% | $81.8M+96.6% | $41.6M+309.6% | $10.2M-46.9% | $19.1M |
| Research and development | $328.8M+8.4% | $303.2M-13.8% | $351.6M-2.8% | $361.6M+51.0% | $239.4M |
| Selling, general and administrative | $548.9M+12.4% | $488.4M+20.1% | $406.6M+10.2% | $369.1M-6.8% | $396.0M |
| Gain on sale of non-financial asset | $0+100.0% | -$146.5M | — | — | — |
| Total operating expenses | $966.7M+33.0% | $727.0M-9.1% | $799.8M+8.0% | $740.8M+13.2% | $654.6M |
| Income (loss) from operations | $104.8M-54.6% | $230.8M+414.5% | -$73.4M+67.2% | -$223.6M-31.2% | -$170.4M |
| Interest income, net | $31.7M+24.6% | $25.5M+47.7% | $17.2M+160.7% | $6.6M+1018.4% | $591K |
| Other income | $2.4M+30.1% | $1.8M-64.3% | $5.1M+44.2% | $3.5M+52.1% | $2.3M |
| Income (loss) before income taxes | $138.9M-46.2% | $258.1M+605.7% | -$51.0M+76.1% | -$213.4M-27.4% | -$167.5M |
| Income tax (benefit) expense | -$252.1M-897.2% | $31.6M+208.5% | $10.3M+305.0% | $2.5M+621.1% | $351K |
| Consolidated net income | $391.0M+72.7% | $226.5M+469.5% | -$61.3M+71.6% | -$216.0M-28.7% | -$167.9M |
| Earnings (net loss) per share, Basic | $2320.00+69.3% | $1370.00+470.3% | -$370.00+72.4% | -$1340.00-27.6% | -$1050.00 |
| Earnings (net loss) per share, diluted | $2300.00+69.1% | $1360.00+467.6% | -$370.00+72.4% | -$1340.00-27.6% | -$1050.00 |
| Weighted average common shares outstanding, basic | 168.4M+1.6% | 165.7M+1.2% | 163.8M+1.3% | 161.7M+0.7% | 160.5M |
| Weighted average common shares outstanding, diluted | 169.9M+2.1% | 166.4M+1.6% | 163.8M+1.3% | 161.7M+0.7% | 160.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.